Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis.

Naumann M, Peikert K, Günther R, van der Kooi AJ, Aronica E, Hübers A, Danel V, Corcia P, Pan-Montojo F, Cirak S, Haliloglu G, Ludolph AC, Goswami A, Andersen PM, Prudlo J, Wegner F, Van Damme P, Weishaupt JH, Hermann A.

Ann Clin Transl Neurol. 2019 Nov 4. doi: 10.1002/acn3.50930. [Epub ahead of print]

2.

NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's disease.

Brummer T, Müller SA, Pan-Montojo F, Yoshida F, Fellgiebel A, Tomita T, Endres K, Lichtenthaler SF.

EMBO Mol Med. 2019 Apr;11(4). pii: e9695. doi: 10.15252/emmm.201809695.

3.

Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation.

Naumann M, Pal A, Goswami A, Lojewski X, Japtok J, Vehlow A, Naujock M, Günther R, Jin M, Stanslowsky N, Reinhardt P, Sterneckert J, Frickenhaus M, Pan-Montojo F, Storkebaum E, Poser I, Freischmidt A, Weishaupt JH, Holzmann K, Troost D, Ludolph AC, Boeckers TM, Liebau S, Petri S, Cordes N, Hyman AA, Wegner F, Grill SW, Weis J, Storch A, Hermann A.

Nat Commun. 2018 Jan 23;9(1):335. doi: 10.1038/s41467-017-02299-1.

4.

A study on the modulation of alpha-synuclein fibrillation by Scutellaria pinnatifida extracts and its neuroprotective properties.

Sashourpour M, Zahri S, Radjabian T, Ruf V, Pan-Montojo F, Morshedi D.

PLoS One. 2017 Sep 28;12(9):e0184483. doi: 10.1371/journal.pone.0184483. eCollection 2017.

5.

Long-term kinetics of Zika virus RNA and antibodies in body fluids of a vasectomized traveller returning from Martinique: a case report.

Froeschl G, Huber K, von Sonnenburg F, Nothdurft HD, Bretzel G, Hoelscher M, Zoeller L, Trottmann M, Pan-Montojo F, Dobler G, Woelfel S.

BMC Infect Dis. 2017 Jan 10;17(1):55. doi: 10.1186/s12879-016-2123-9.

6.

Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson's disease.

Hu Q, Uversky VN, Huang M, Kang H, Xu F, Liu X, Lian L, Liang Q, Jiang H, Liu A, Zhang C, Pan-Montojo F, Zhu S.

Biochim Biophys Acta. 2016 Oct;1862(10):1883-90. doi: 10.1016/j.bbadis.2016.07.008. Epub 2016 Jul 15.

7.

Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson's disease.

Arnhold M, Dening Y, Chopin M, Arévalo E, Schwarz M, Reichmann H, Gille G, Funk RH, Pan-Montojo F.

Clin Auton Res. 2016 Jun;26(3):211-22. doi: 10.1007/s10286-016-0358-6. Epub 2016 May 13.

8.

Cuminaldehyde as the Major Component of Cuminum cyminum, a Natural Aldehyde with Inhibitory Effect on Alpha-Synuclein Fibrillation and Cytotoxicity.

Morshedi D, Aliakbari F, Tayaranian-Marvian A, Fassihi A, Pan-Montojo F, Pérez-Sánchez H.

J Food Sci. 2015 Oct;80(10):H2336-45. doi: 10.1111/1750-3841.13016. Epub 2015 Sep 9.

PMID:
26351865
9.

Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 Cells.

Khalife M, Morshedi D, Aliakbari F, Tayaranian Marvian A, Mohammad Beigi H, Azimzadeh Jamalkandi S, Pan-Montojo F.

Protein J. 2015 Aug;34(4):291-303. doi: 10.1007/s10930-015-9625-y.

PMID:
26250981
10.

Products of the Parkinson's disease-related glyoxalase DJ-1, D-lactate and glycolate, support mitochondrial membrane potential and neuronal survival.

Toyoda Y, Erkut C, Pan-Montojo F, Boland S, Stewart MP, Müller DJ, Wurst W, Hyman AA, Kurzchalia TV.

Biol Open. 2014 Jul 25;3(8):777-84. doi: 10.1242/bio.20149399.

11.

Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiology.

Pan-Montojo F, Reichmann H.

Transl Neurodegener. 2014 May 9;3:10. doi: 10.1186/2047-9158-3-10. eCollection 2014. Review.

12.

Hierarchically structured nerve guidance channels based on poly-3-hydroxybutyrate enhance oriented axonal outgrowth.

Hinüber C, Chwalek K, Pan-Montojo FJ, Nitschke M, Vogel R, Brünig H, Heinrich G, Werner C.

Acta Biomater. 2014 May;10(5):2086-95. doi: 10.1016/j.actbio.2013.12.053. Epub 2014 Jan 7.

PMID:
24406197
13.

Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.

Wagner J, Ryazanov S, Leonov A, Levin J, Shi S, Schmidt F, Prix C, Pan-Montojo F, Bertsch U, Mitteregger-Kretzschmar G, Geissen M, Eiden M, Leidel F, Hirschberger T, Deeg AA, Krauth JJ, Zinth W, Tavan P, Pilger J, Zweckstetter M, Frank T, Bähr M, Weishaupt JH, Uhr M, Urlaub H, Teichmann U, Samwer M, Bötzel K, Groschup M, Kretzschmar H, Griesinger C, Giese A.

Acta Neuropathol. 2013 Jun;125(6):795-813. doi: 10.1007/s00401-013-1114-9. Epub 2013 Apr 19.

14.

Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice.

Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O'Sullivan GA, Pal A, Said J, Marsico G, Verbavatz JM, Rodrigo-Angulo M, Gille G, Funk RH, Reichmann H.

Sci Rep. 2012;2:898. doi: 10.1038/srep00898. Epub 2012 Nov 30.

15.
16.
17.

Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice.

Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH.

PLoS One. 2010 Jan 19;5(1):e8762. doi: 10.1371/journal.pone.0008762.

Supplemental Content

Loading ...
Support Center